Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 4:59 pm Purchase | 13G | SI-BONE INC SIBN | ORBIMED ADVISORS LLC | 3,201,100 9.3% | 3,201,100 (New Position) | View |
| 2023-02-14 4:55 pm Sale | 13G | RXSIGHT INC RXST | ORBIMED ADVISORS LLC | 923,733 3.3% | -138,767 (-13.06%) | View |
| 2023-02-14 4:52 pm Unchanged | 13G | PROTARA THERAPEUTICS INC TARA | ORBIMED ADVISORS LLC | 671,741 6% | 0 (Unchanged) | View |
| 2023-02-14 4:48 pm Unchanged | 13G | NEUROPACE INC NPCE | ORBIMED ADVISORS LLC | 4,012,281 16.1% | 0 (Unchanged) | View |
| 2023-02-14 4:43 pm Purchase | 13G | MERSANA THERAPEUTICS INC MRSN | ORBIMED ADVISORS LLC | 7,082,837 7.1% | 7,082,837 (New Position) | View |
| 2023-02-14 4:40 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | ORBIMED ADVISORS LLC | 10,378,591 5.92% | 4,315,246 (+71.17%) | View |
| 2023-02-14 4:37 pm Sale | 13G | MEIRAGTX HLDGS PLC MGTX | ORBIMED ADVISORS LLC | 0 0% | -3,593,966 (Position Closed) | View |
| 2023-02-14 4:32 pm Purchase | 13G | KEZAR LIFE SCIENCES INC KZR | ORBIMED ADVISORS LLC | 3,495,122 5.1% | 3,495,122 (New Position) | View |
| 2023-02-14 4:30 pm Sale | 13G | JOUNCE THERAPEUTICS INC. JNCE | ORBIMED ADVISORS LLC | 0 0% | -2,200,200 (Position Closed) | View |
| 2023-02-14 4:25 pm Sale | 13G | HARPOON THERAPEUTICS INC HARP | ORBIMED ADVISORS LLC | 804,206 2.4% | -863,694 (-51.78%) | View |
| 2023-02-14 4:20 pm Unchanged | 13G | GRACELL BIOTECHNOLOGIES INC SP GRCL | ORBIMED ADVISORS LLC | 5,970,672 8.8% | 0 (Unchanged) | View |
| 2023-02-14 4:12 pm Unchanged | 13G | CRINETICS PHARMACEUTICALS INC CRNX | ORBIMED ADVISORS LLC | 3,196,876 5.9% | 0 (Unchanged) | View |
| 2023-02-14 4:09 pm Sale | 13G | CATALYST BIOSCIENCES INC N CBIO | ORBIMED ADVISORS LLC | 0 0% | -1,350,602 (Position Closed) | View |
| 2023-02-14 4:07 pm Purchase | 13G | APPLIED THERAPEUTICS INC APLT | ORBIMED ADVISORS LLC | 7,300,921 9.99% | 5,200,240 (+247.55%) | View |
| 2023-02-14 4:06 pm Purchase | 13G | ALX ONCOLOGY HLDGS INC ALXO | ORBIMED ADVISORS LLC | 2,266,000 5.6% | 2,266,000 (New Position) | View |
| 2023-02-14 4:01 pm Sale | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | ORBIMED ADVISORS LLC | 1,797,221 2.9% | -2,158,903 (-54.57%) | View |
| 2023-01-26 4:40 pm Sale | 13D | 89BIO INC ETNB | ORBIMED ADVISORS LLC | 1,504,436 3.2% | -325,000 (-17.77%) | View |
| 2023-01-05 4:40 pm Sale | 13D | SPRINGWORKS THERAPEUTICS INC C SWTX | ORBIMED ADVISORS LLC | 4,985,000 8% | -614,842 (-10.98%) | View |
| 2023-01-03 5:23 pm Purchase | 13D | DISC MEDICINE INC IRON | ORBIMED ADVISORS LLC | 2,160,941 12.8% | 2,160,941 (New Position) | View |
| 2022-12-28 5:14 pm Purchase | 13D | TERNS PHARMACEUTICALS INC TERN | ORBIMED ADVISORS LLC | 7,619,135 15.4% | 137,931 (+1.84%) | View |